Tumor-Specific Growth Factor (TSGF): A Futuristic Tumor Biomarker in Early Diagnosis of Cancer

Bhagyalakshmi Nair ¹ , Anisha Kuriakose ¹ , Bilha Baby ¹, Lekshmi.R. Nath ¹ *

Cited by CrossRef: 3

1- Ding N. Predictive value of serum alkaline phosphatase, tumor-specific growth factor, and macrophage migration inhibitory factor for the efficacy of immunotargeted therapy in osteosarcoma patients. Am J Cancer Res. 2024;14(7):3545 [Crossref]

2- Ganesh B, Aruchamy B, Ramani P, Zara S, Carradori S, D'Agostino S, Mathew B. Exploration of N‐Tetra‐Substituted Imidazoles as Effective Agents To Counteract Gastric Cancer Cell Viability: Synthesis and Biological Evaluation. ChemistrySelect. 2023;8(48) [Crossref]

3- Arefnezhad R, Ashna S, Rezaei‐Tazangi F, Arfazadeh S, Seyedsalehie S, Yeganeafrouz S, Aghaei M, Sanandaji M, Davoodi R, Abadi S, Vosough M. Noncoding RNAs and programmed cell death in hepatocellular carcinoma: Significant role of epigenetic modifications in prognosis, chemoresistance, and tumor recurrence rate. Cell Biology International. 2024;48(5):556 [Crossref]

4- Sun A, Chen H, Shi X, Shang Z, Zhang J. Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis. The American Surgeon™. 2024; [Crossref]